Temporary Wet Strength Agents And Products Made From Such Agents
Abstract
The invention relates to a tissue product that includes (a) a tissue fibrous web incorporated throughout the tissue product; (b) a temporary wet strength agent capable of forming hemi-acetal bonds with the fibers of the web to prevent immediate degradation of the web when the tissue product contacts water; and (c) a composition containing a degrading agent selected from the group consisting of alkaline agents, oxidizing agents, nucleophilic agents, and combinations thereof. The invention also relates to compositions used to make such a tissue product as well as methods for making and using such compositions.
Claims
exact text as granted — not AI-modified1 . A tissue product comprising:
(a) a tissue fibrous web incorporated throughout the tissue product; (b) a temporary wet strength agent capable of forming hemi-acetal bonds with the fibers of the web to prevent immediate degradation of the web when the tissue product contacts water; and (c) a composition containing a degrading agent selected from the group consisting of alkaline agents, oxidizing agents, nucleophilic agents, and combinations thereof; wherein the degrading agent is located throughout the fibrous web and the degrading agent is present throughout the tissue product in an amount that is sufficient to make the fibrous web exhibit (i) an immediate wet tensile strength of at least 90% of the wet strength as compared to a web that does not contain a degrading agent and (ii) a wet soak decay that is at least a ten point improvement as compared to a tissue fibrous web that does not contain a degrading agent.
2 . The tissue product of claim 1 , wherein the temporary wet strength agent is a glyoxylated polyacrylamide.
3 . The tissue product of claim 2 , wherein the glyoxylated polyacrylamide is added at an amount of from about 0.05% to about 1.0% by dry weight of the fibrous web.
4 . The tissue product of claim 1 , wherein the composition containing the degrading agent includes a charged moiety including (1) a core component selected from the group consisting of alkaline agents, oxidizing agents, nucleophilic agents, and combinations thereof and (2) a charged coating that surrounds at least a portion of the core component.
5 . The tissue product of claim 4 , wherein the charged coating is a cationically charged coating is a surfactant having an HLB value that is more than 3.
6 . The tissue product of claim 4 , wherein the composition containing the degrading agent component comprises an anionically charged moiety including a core alkaline component and an anionically charged coating covering at least a portion of the core alkaline component.
7 . The tissue product of claim 5 , wherein the cationically charged coating comprises solid quatemary ammonium compounds.
8 . The tissue product of claim 1 , wherein the composition containing the degrading agent component comprises (i) a liquid degradation inhibiting carrier and (ii) a degrading agent selected from the group consisting of oxidizing agents, nucleophilic agents, and alkaline agents and combinations thereof.
9 . The tissue product of claim 8 , wherein the composition containing the degrading agent component comprises the degrading agent and a liquid degradation inhibiting carrier.
10 . The tissue product of claim 8 , wherein the degrading agent is a solid moiety suspended in liquid particles.
11 . The tissue product of claim 9 , wherein the carrier is hydrophobic.
12 . The tissue product of claim 9 , wherein the carrier is selected from the group consisting of (1) mixtures containing materials selected from the group consisting of water, mineral oil, petrolatum, sorbitol, stearic acid, lanolin, lanolin alcohol, cetyl alcohol, glyceryl stearate, PEG-100 stearate, triethanolamine, dimethicone, propylene glycol, microcrystalline wax, triethyl citrate, PPG-3 myristyl ether, disodium EDTA, methylparaben, ethylparaben, propylparaben, fragrance, xanthan gum, butylparaben, methyldibromo glutaronitrile, aand combinations thereof, (2) lotions containing materials selected from the group consisting of water, glycerin, sodium myristoyl sarcosina, PEG-120 methyl glucose dioleate, sodium lauroamphoacetate, disodium lauroamphoacetate, glycol distearate, PEG-150 pentaerithritol tetra stearate, sodium tridecethsulfate, polyquaternium-10, sodium laureth sulfate, phenoxyethanol, cocamide mea, citric acid, DADM hydantoin, disodium EDTA, laureth-10, fragrance, and combinations thereof, (3) creams containing materials selected from the group consisting of water, sodium C 14-16 olefin sulfonate, cocamidopropyl betaine, cetyl alcohol, stearyl alcohol, di-C- 12-15 alkyl fumarate, coco-glucoside, coconut alcohol, sodium methyl cocoyl taurate, DEA-cetyl phosphate, matriciaria (chamomilla recutita) flower extract, aloe barbadensis leaf extract, chamonile (anthemis nobiiis) flower extract, hydroxypropyl methylcellulose, potato (sodium tuberosum) strach, propylene glycol, fragrance, and combinations thereof, (4) creams containing materials selected from the group consisting of water, sodium cocoyl isethionate, propylene glycol, stearic acid, cetearyl alcohol, cocoamidopropyl betaine, hydroxypropyl methylcellulose, sodium lauroyl sarcosinate, salicylic acid, menthol, fragrance, magnesium aluminum silicate, disodium EDTA, methylparaben, propylparaben, DADM hydantonin, titanium dioxide, and combinations thereof, (5) tetra-alkyl anunonium chlorides, (6) quaternary amine tetra alkyl ammonium chlorides, (7) sodium dioctyl sulfosuccinates in petroleum distillates, (8) polyoxyethylene(10) oleyl ethers, (9)polyoxyethylene(2) cetyl ethers, and combinations thereof.
13 . The tissue product of claim 1 , wherein the alkaline reagent component excludes sodium acetate, sodium benzoate, sodium carbonate, sodium bicarbonate, calcium carbonate, calcium bicarbonate, and combinations thereof.
14 . In a process for forming a tissue product from a tissue fibrous web, the improvement comprising the addition to the wet-end of the tissue product forming process of a composition containing a degrading agent selected from the group consisting of alkaline agents, oxidizing agents, nucleophilic agents, and combinations thereof;
wherein the degrading agent is located throughout the fibrous web formed by the process and the degrading agent is present throughout the tissue product in an amount that is sufficient to make the fibrous web exhibit (i) an immediate wet tensile strength of at least 90% of the wet strength as compared to a web that does not contain a degrading agent and (ii) a wet soak decay that is at least a ten point improvement as compared to a tissue fibrous web that does not contain a degrading agent.
15 . A composition comprising a formulation including:
(a) a degrading agent selected from the group consisting of alkaline agents, oxidizing agents, nucleophilic agents, and combinations thereof; and (b) a degradation inhibiting carrier component; wherein the degrading agent is present throughout the tissue product in a sufficient amount to make a tissue fibrous web containing the composition exhibit (i) an immediate wet tensile strength of at least 90% of the wet strength as compared to a web that does not contain a degrading agent and (ii) a wet soak decay that is at least a ten point improvement as compared to a tissue fibrous web that does not contain a degrading agent.
16 . The composition of claim 15 , wherein the degradation inhibiting carrier component is hydrophobic.
17 . The composition of claim 15 , wherein the degradation inhibiting carrier component is selected from the group consisting of (1) mixtures containing materials selected from the group consisting of water, mineral oil, petrolatum, sorbitol, stearic acid, lanolin, lanolin alcohol, cetyl alcohol, glyceryl stearate, PEG-100 stearate, triethanolamine, dimethicone, propylene glycol, microcrystalline wax, triethyl citrate, PPG-3 myristyl ether, disodium EDTA, methylparaben, ethylparaben, propylparaben, fragrance, xanthan gum, butylparaben, methyldibromo glutaronitrile, and combinations thereof, (2) lotions containing materials selected from the group consisting of water, glycerin, sodium myristoyl sarcosina, PEG-120 methyl glucose dioleate, sodium lauroamphoacetate, disodium lauroamphoacetate, glycol distearate, PEG-150 pentaerithritol tetra stearate, sodium tridecethsulfate, polyquaternium10, sodium laureth sulfate, phenoxyethanol, cocamide mea, citric acid, DADM hydantoin, disodium EDTA, laureth-10, fragrance, and combinations thereof, (3) creams containing materials selected from the group consisting of water, sodium C 14-16 olefin sulfonate, cocamidopropyl betaine, cetyl alcohol, stearyl alcohol, di-C- 12-15 alkyl fumarate, coco-glucoside, coconut alcohol, sodium methyl cocoyl taurate, DEA-cetyl phosphate, matriciaria (chamomilla recutita) flower extract, aloe barbadensis leaf extract, chamonile (anthemis nobiiis) flower extract, hydroxypropyl methylcellulose, potato (sodium tuberosum) strach, propylene glycol, fragrance, and combinations thereof, (4) creams containing materials selected from the group consisting of water, sodium cocoyl isethionate, propylene glycol, stearic acid, cetearyl alcohol, cocoamidopropyl betaine, hydroxypropyl methylcellulose, sodium lauroyl sarcosinate, salicylic acid, menthol, fragrance, magnesium aluminum silicate, disodium EDTA, methylparaben, propylparaben, DADM hydantonin, titanium dioxide, and combinations thereof, (5) tetra-alkyl ammonium chlorides, (6) quaternary amine tetra alkyl ammonium chlorides, (7) sodium dioctyl sulfosuccinates in petroleum distillates, (8) polyoxyethylene(10) oleyl ethers, (9)polyoxyethylene(2) cetyl ethers, and combinations thereof.
18 . A composition comprising a charged moiety including (1) a core component selected from the group consisting of oxidizing agents, nucleophilic agents, and combinations thereof and a (2) a charged coating that surrounds at least a portion of the core component;
wherein the degrading agent is present throughout the tissue product in a sufficient amount to make a tissue fibrous web containing the composition exhibit (i) an immediate wet tensile strength of at least 90% of the wet strength as compared to a web that does not contain a degrading agent and (ii) a wet soak decay that is at least a ten point improvement as compared to a tissue fibrous web that does not contain a degrading agent.
19 . A composition comprising a tissue having an absorbent fibrous cellulosic web, wherein the tissue includes a combination of:
(1) a total area ranging from 100 to 150cm 2 ; (2) a basis weight ranging from 5 to 50 gsm; (3) a degrading agent located throughout the fibrous cellulosic web, wherein the degrading agent is selected from the group consisting of alkaline agents, oxidizing agents, nucleophilic agents, and combinations thereof (4) an immediate wet tensile strength of at least 90% of the wet strength as compared to a web that does not contain a degrading agent and (5) a wet soak decay that is at least a ten point improvement as compared to a tissue fibrous web that does not contain a degrading agent.
20 . A composition comprising a tissue having an absorbent fibrous cellulosic web, wherein the tissue includes a combination of:
(1) a total area ranging from 100 to 150cm 2 ; (2) a basis weight ranging from 5 to 50 gsm; (43) an initial wet tensile strength that is at least 10 g/cm 2 (4) an improved decay that is at least 10 points; (45) an absorbency that is less than 25 seconds, as measured by the water drop test.Join the waitlist — get patent alerts
Track US2008017339A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.